Clinical Trial: A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects.

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07521345) titled 'A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects.' on April 03.

Brief Summary: This is a single-center, random, double blind, placebo control clinical study to evaluate the safety, tolerability pharmacokinetics and food effect of HSK55879 in healthy subjects

Study Start Date: March 20

Study Type: INTERVENTIONAL

Condition: Healhty

Intervention: DRUG: HSK55879

Dose 1 to dose 5

DRUG: Placebo

dose 1 to dose 5

Recruitment Status: RECRUITING

Sponsor: Haisco Pharmaceutical Group Co., Ltd.

Disclaimer: Curated by HT Syndication....